Sweet BV의 rat를 이용한 단회 근육시술 독성시험
Study of single dose test of Sweet Bee Venom in rats
2
조회
0
다운로드
14
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to analyse single dose toxicity of pure melittin(Sweet Bee Venom-Sweet BV) extracted from the bee venom by utilizing protein isolation method of gel filtration. Methods: All experiments were conducted at Biotoxtech, a non-clinical studies authorized institution, under the regulations of Good Laboratory Practice (GLP). Six weeks old female Sprague-Dawley rats were chosen for the pilot study and determined 30㎎/㎏ which is 4285 times higher than the clinical application dosage as the high dosage, followed by 15 and 7.5㎎/㎏ as mid and lose dosage, respectively. Equal amount of excipient to the Sweet BV experiment groups was administered as the control group. Results: 1. No mortality was witnessed in all of the experiment groups. 2. Hyperemia and movement disorder were observed around the area of administration in all groups, and higher occurrence in the higher dosage groups. Hyperemia and movement disorder diminished with elapsed time. 3. For the weight measurement, male groups showed larger reduction in weight in accordance with higher dosage. Female groups didn't s how significant changes. 4. To verify abnormalities of organs and tissues, cerebellum, cerebrum, liver, lung, kidney, and spinal nerves were removed and conducted histological observation with H-E staining. No abnormalities were detected in any of organs and tissues. 5. One female rat in the 30㎎/㎏ group had amputated toe near the administered area and histopathological finding was hemorrhage with inflammation. This is presumed as a secondary infection after the administration of Sweet BV. Conclusion: Above findings suggest Sweet BV is relatively s safe treatment medium. Further studies on the subject should be conducted to yield more concrete evidences.
Abstract
Objectives: This study was performed to analyse single dose toxicity of pure melittin(Sweet Bee Venom-Sweet BV) extracted from the bee venom by utilizing protein isolation method of gel filtration. Methods: All experiments were conducted at Biotoxtech, a non-clinical studies authorized institution, under the regulations of Good Laboratory Practice (GLP). Six weeks old female Sprague-Dawley rats were chosen for the pilot study and determined 30㎎/㎏ which is 4285 times higher than the clinical application dosage as the high dosage, followed by 15 and 7.5㎎/㎏ as mid and lose dosage, respectively. Equal amount of excipient to the Sweet BV experiment groups was administered as the control group. Results: 1. No mortality was witnessed in all of the experiment groups. 2. Hyperemia and movement disorder were observed around the area of administration in all groups, and higher occurrence in the higher dosage groups. Hyperemia and movement disorder diminished with elapsed time. 3. For the weight measurement, male groups showed larger reduction in weight in accordance with higher dosage. Female groups didn't s how significant changes. 4. To verify abnormalities of organs and tissues, cerebellum, cerebrum, liver, lung, kidney, and spinal nerves were removed and conducted histological observation with H-E staining. No abnormalities were detected in any of organs and tissues. 5. One female rat in the 30㎎/㎏ group had amputated toe near the administered area and histopathological finding was hemorrhage with inflammation. This is presumed as a secondary infection after the administration of Sweet BV. Conclusion: Above findings suggest Sweet BV is relatively s safe treatment medium. Further studies on the subject should be conducted to yield more concrete evidences.
참고문헌 (34)
- 대한약침학회학술위원회, "Pharmacopuncturology", pp.167~199 (2008), Elsevier Korea
- Kwon KR, "An Experimental Study with Bee Venom Therapy on Anti-inflammatory and Analgesic Effects", The Journal of Korean Acupuncture & Moxibustion Society, 15(2), pp.97~103 (1998)
- Ko HK, "Experimental Studies on the Effect of Bee Venom Theraphy on the Analgesic, Antipyretic and Anti-inflammatory Action", Korean Journal of Oriental Medicine, 13(1), pp.283~292 (1992)
- Kwon KR, "The Effect of Bee Venom Aqua - acupuncture on the Antitumor and Immune Response in the Epithelioma by 3 - MCA", The Journal of Korean Acupuncture & Moxibustion Society, 14(2), pp.151~172 (1997)
- Lee SN, "The Clinical Study on Bee Venom Acupuncture Treatment on Osteoarthritis of Knee Joint", The Journal of Korean Acupuncture & Moxibustion Society, 20(5), pp.73~78 (2003)
- Wang WH, "Clincal Investigation Compared with the Effects of the Bee Venom - Acupuncture on Knee Joint with Osteoarthritis", The Journal of Korean Acupuncture & Moxibustion Society, 18(3), pp.35~47 (2001)
- Kim TH, "Three cases of affections of the hip treated with Korean Bee-Venom therapy", Journal of Korean Pharmacopuncture Institute, 4(3), pp.122~130 (2001)
- 이상훈, "봉독약침이 류마티스 관절염 환자의 관절 통증, 종창 및 급성 염증 반응에 미치는 영향", 대한침구학회지, 20(2), pp.7~84 (2003), 대한침구학회
- 이상훈, "무작위 대조 이중맹검 시험을 통한 봉독 약침의 류마티스 관절염 치료 효과 연구", 대한침구학회지, 20(6), pp.9~ (2003), 대한침구학회
- Kin KU, "The Comparison of Bee Venom Herbalacupuncture Therapy between Neighboring Acupuncture Points and Neighboring-Remote Acupuncture Points on the Treatment of Lumbar Spine Herniation of Nucleus Pulpous", The Journal of Korean Acupuncture & Moxibustion Society, 22(6), pp.181~187 (2005)
- 이건목, "蜂藥鍼을 위주로 한 腰椎椎間板脫出症 의 突出型 患者(protrusion disc patients) 에 대한 臨床的 考察", 대한침구학회지, 21(5), pp.13~26 (2004), 대한침구학회
- 전형준, "봉약침으로 치료한 요추간판탈출증 환자의 임상적 평가", 대한침구학회지, 20(5), pp.7~ (2003), 대한침구학회
- 이대용, "中風後遺症으로 인한 肩臂痛 患者의 蜂藥鍼治療에 대한 臨床的 考察", 대한침구학회지, 23(4), pp.69~80 (2006), 대한침구학회
- 정경숙, "뇌졸중 후 중추성 통증 환자에 대한 봉독약침요법 치료 효과에 대한 임상적 연구", 대한침구의학회지, 22(3), pp.69~76 (2005), 대한침구의학회
- 최영권, "Gel filtration chromatography와 propionic acid", urea polyacrylamide gel electrophoresis를 이용한 봉독 성분의 분리, 2006, pp.9(2), 105~111[DOI]
- Barbara & Rudolf, "Chemistry and Pharmacology of Honey Bee venom", pp.329~402 (1986), Academic Press
- Park HJ, "Antiarthritic effect of Bee Venom", Arthritis & Rheumatism, 50(11), pp.3504~3515 (2004)
- Park HJ, "JNK pathway is involved on the inhibition of inflammatory target gene expression and NF-κB activation by melittin", J. Inflammation, 5(7), pp.1~13 (2008)
- 허인회, "독성학", pp.9~10 (1993), 신일상사
- 김양강, "독성학", pp.15~18 (1984), 동화기술
- 식품의약품안정청, "식품의약품안전청고시 제2005-60호", ~
- 식품의약품안정청, "식품의약품안전청고시 제2008-56호", ~
- 강계성, "다발성 경화증 환자 5례에 대한 임상보고", 대한침구학회지, 20(1), pp.2~ (2003), 대한침구학회
- 권기록, "한방치료를 통한 근위축성 측삭경화증(ALS)의 임상적 연구", 대한침구학회지, 20(3), pp.17~216 (2003), 대한침구학회
- Lee JS, "A Clinical Study on the case of Fascioscapulohumeral ( FSH ) Muscular Dystrophy Treated with Traditional Korean Medicine", The Journal of Korean Acupuncture & Moxibustion Society, 18(3), pp.227~238 (2001)
- Hwang YJ, "Clinical Study of Anaphylaxis on Bee-Venom Acupuncture", The Journal of Korean Acupuncture & Moxibustion Society, 17(4), pp.149~159 (2000)
- 윤현민, "봉약침요법으로 발생한 Anaphylaxis에 대한 임상보고", 대한침구학회지, 22(4), pp.179~188 (2005), 대한침구학회
- Robert L, "Allergy, Hypersensitivity, Anaphylaxis", pp.2759~2766 (1998), Mosby Year Book
- 권기록, "Sweet BV의 성분분석과 항체역가 및 allergy 반응에 대한 임상적 연구", 대한약침학회지, 9(2), pp.79~86 (2006), 대한약침학회
- 이진선, "봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구", 대한약침학회지, 9(3), pp.61~77 (2006), 대한약침학회
- Renata MS, "Structural and functional behavior of biologically active monomeric melittin", J Molecular Graphics and Modelling, 25, pp.767~772 (2007)
- Lind DS, "nuclear factor-κB is upregulated in colorectal cancer", Surgery, 130, pp.363~369 (2001)
- Aranha MM, "NF-κB and apotosis in colorectal tumorigenesis", Eur J Clin Invest., 37, pp.416~424 (2007)
- 권기록, "Sweet BV의 함량분석과 시술 부위별 LD50관찰", 대한약침학회지, 10(2), pp.81~86 (2007), 대한약침학회